International Stem Cell CORP Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
International Stem Cell CORP quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • International Stem Cell CORP Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 120M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 120M 0 0% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 120M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 120M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 120M 0 0% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 120M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 120M 0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 120M 0 0% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 120M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 120M 0 0% Sep 30, 2022 10-Q 2023-05-12
Q2 2022 120M 0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 120M 0 0% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 120M 0 0% Dec 31, 2021 10-Q 2023-05-12
Q3 2021 120M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 120M 0 0% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 120M 0 0% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 120M 0 0% Dec 31, 2020 10-K 2022-03-29
Q3 2020 120M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 120M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 120M 0 0% Mar 31, 2020 10-Q 2020-06-19
Q4 2019 120M 0 0% Dec 31, 2019 10-K 2021-03-30
Q3 2019 120M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 120M 0 0% Jun 30, 2019 10-Q 2019-08-27
Q1 2019 120M 0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 120M 0 0% Dec 31, 2018 10-K 2020-06-01
Q3 2018 120M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 120M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 120M 0 0% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 120M 0 0% Dec 31, 2017 10-K 2019-04-15
Q3 2017 120M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 120M 0 0% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 120M -600M -83.3% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 120M -600M -83.3% Dec 31, 2016 10-K 2018-04-09
Q3 2016 120M -600M -83.3% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 120M -600M -83.3% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 720M 0 0% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 720M 0 0% Dec 31, 2015 10-K 2017-03-31
Q3 2015 720M +120M +20% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 720M +120M +20% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 720M +420M +140% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 720M +420M +140% Dec 31, 2014 10-K 2016-03-30
Q3 2014 600M +300M +100% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 600M +300M +100% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 300M 0 0% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 300M 0 0% Dec 31, 2013 10-K 2015-03-30
Q3 2013 300M 0 0% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 300M 0 0% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 300M +100M +50% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 300M +100M +50% Dec 31, 2012 10-K 2014-03-17
Q3 2012 300M +100M +50% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 300M +100M +50% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 200M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 200M 0 0% Dec 31, 2011 10-K 2013-03-26
Q3 2011 200M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 200M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 200M Dec 31, 2010 10-K 2012-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.